Skip to content
SafetyScorer

Is Duloxetine safe?

Duloxetine

Duloxetine (Cymbalta) is an SNRI for depression, anxiety and chronic pain such as diabetic nerve pain. It is not addictive and rarely fatal in overdose on its own. The catches are early nausea, symptoms on stopping, rare serious liver injury and many interactions.

High confidence#49 of 82 medications
Updated
Spot a mistake?

#49of 82 medications

High confidence
Brands
Cymbalta, Yentreve (EU, for stress urinary incontinence), generics
Usual adult dose (US label)
60 mg once a day for depression, anxiety and pain; maximum 120 mg a day (depression, anxiety), 60 mg a day (pain)
Drug class
Serotonin and noradrenaline reuptake inhibitor (SNRI)
Boxed warning
Suicidal thoughts and behaviours in children, teenagers and young adults
Half-life
About 12 hours (8 to 17)
Avoid with
Heavy alcohol use, chronic liver disease, fluvoxamine and other strong CYP450 enzymesA family of liver enzymes that break down many medicines. When another drug or supplement speeds them up or slows them down, drug levels change.More in the glossary inhibitors, MAOIs
Controlled substance
No
US prescriptions (2024)
About 17.9 million, ranked 34th (ClinCalc)

How the score breaks down

The overall score is the weighted average of these factors. Scoring rules

  • Serious side effects30% of score

    64 out of 100, Fair

    In depression trials 8.4% stopped for side effects against 4.6% on placebo; nausea hit 23% against 8%. Serious risks include fatal liver failure (rare; ALT over 3 times normal in 1.25% vs 0.45%), Serotonin syndromeA reaction caused by too much serotonin in the body, usually from combining medicines that raise it. Symptoms range from shivering to high fever.More in the glossary, bleeding, low sodium, falls from low blood pressure and severe skin reactions.

  • Overdose margin20% of score

    75 out of 100, Good

    The Cymbalta label reports deaths, mostly in mixed overdoses but also with duloxetine alone at 1,000 mg. In a 2022 series of 64 duloxetine-only overdoses (median 840 mg), none needed intubation or had arrhythmias; six had moderate Serotonin syndromeA reaction caused by too much serotonin in the body, usually from combining medicines that raise it. Symptoms range from shivering to high fever.More in the glossary.

  • Interactions15% of score

    52 out of 100, Weak

    MAOIs, linezolid and IV methylene blue are ContraindicationA situation in which a medicine should not be used, because the risk clearly outweighs any benefit, such as a known allergy to it.More in the glossary. Fluvoxamine raised duloxetine exposure about 6-fold; ciprofloxacin also inhibits CYP450 enzymesA family of liver enzymes that break down many medicines. When another drug or supplement speeds them up or slows them down, drug levels change.More in the glossary. It raises levels of CYP2D6 drugs (thioridazine must be avoided), adds bleeding risk with NSAIDs and warfarin, and heavy alcohol may cause Drug-induced liver injuryLiver damage caused by a medicine, herbal product or supplement. It is usually rare and unpredictable, but it can be serious.More in the glossary.

  • Dependence and misuse15% of score

    72 out of 100, Good

    Not a Controlled substanceA medicine or drug that the law restricts because it can be misused or cause dependence. Countries group them into schedules or classes.More in the glossary and no drug-seeking in trials. Its 12-hour half-life makes discontinuation symptoms (dizziness, nausea, headache, electric-shock sensations, irritability) common after abrupt stops; the label advises a gradual taper.

  • Regulatory warnings10% of score

    48 out of 100, Weak

    Antidepressant class Boxed warningThe strongest safety warning the US FDA puts on a medicine's label, printed inside a black border at the top.More in the glossary on suicidality in under-25s, plus a liver warning. On 15 October 2026 the MHRA named duloxetine among antidepressants getting new leaflet warnings on suicidal thoughts and lasting sexual dysfunction (PSSD).

  • Track record10% of score

    88 out of 100, Excellent

    Cymbalta was approved in the US on 3 August 2004 (NDA 021427) and is now among the top 40 US drugs, with about 17.9 million prescriptions in 2024. Two decades of data cover depression, anxiety and several pain conditions.

Is duloxetine safe?

For most adults it is a reasonable choice, with more trade-offs than the first-choice SSRIs. Duloxetine, sold as Cymbalta, is a serotonin and noradrenaline reuptake inhibitor (SNRI). It treats depression and anxiety, and unlike most antidepressants it is also approved for long-term pain: diabetic nerve pain, fibromyalgia and chronic musculoskeletal pain. It was filled about 17.9 million times in the US in 2024.

It is not addictive, and an overdose of duloxetine alone is rarely life-threatening. Its weak points are side effects that make about one in twelve people stop, withdrawal symptoms after stopping, rare but serious Drug-induced liver injuryLiver damage caused by a medicine, herbal product or supplement. It is usually rare and unpredictable, but it can be serious.More in the glossary and a long list of interactions. We score it 66, below sertraline (72) and above venlafaxine.

What are the side effects of duloxetine?

Most side effects come early and fade. In the label's pooled placebo-controlled trials across all approved adult uses (8,100 people on duloxetine, 5,655 on placebo):

Side effectDuloxetinePlacebo
Nausea23%8%
Headache14%12%
Dry mouth13%5%
Sleepiness10%3%
Fatigue9%5%
Constipation9%4%
Dizziness9%5%
Decreased appetite7%2%
Sweating6%1%

In the depression trials, 8.4% stopped because of side effects against 4.6% on placebo. Sexual side effects are common with all serotonin drugs. On 15 October 2026 the MHRA said UK leaflets for duloxetine and other antidepressants will add the term "post-SSRI sexual dysfunction" (PSSD), because for some people symptoms continue after stopping.

The rarer serious risks include Serotonin syndromeA reaction caused by too much serotonin in the body, usually from combining medicines that raise it. Symptoms range from shivering to high fever.More in the glossary, bleeding (especially with aspirin, NSAIDs or warfarin), low blood sodium in older people, falls from a drop in blood pressure on standing, urinary retention, severe skin reactions, seizures and triggering mania in undiagnosed bipolar disorder.

The liver warning

This is where duloxetine differs from SSRIs. The label reports hepatitis and liver failure, sometimes fatal, with liver enzymes above 20 times normal. In placebo-controlled trials 1.25% of people on duloxetine had an ALT rise above three times the upper limit, against 0.45% on placebo, usually around two months in. Liver problems led 0.3% of trial patients to stop.

Because duloxetine and alcohol may together injure the liver, the label says it should not be prescribed to people with substantial alcohol use or chronic liver disease. Yellow skin or eyes, dark urine, itching or pain under the right ribs are reasons to call your doctor the same day.

The boxed warning on suicidal thoughts

Duloxetine carries the antidepressant class Boxed warningThe strongest safety warning the US FDA puts on a medicine's label, printed inside a black border at the top.More in the glossary. In pooled short-term trials across antidepressants, there were 14 extra cases of suicidal thinking or behaviour per 1,000 patients under 18, and 5 extra per 1,000 aged 18 to 24; there was no increase after 24 and a reduction from 65. Watch closely in the first months and after dose changes, and contact the prescriber the same day about agitation, worsening mood or thoughts of self-harm. In the UK, the Samaritans are on 116 123.

Stopping duloxetine and withdrawal

Duloxetine has a half-life of about 12 hours, much shorter than fluoxetine's, so levels fall fast after a missed dose or an abrupt stop. In the label's trials, dizziness, headache, nausea, diarrhoea, pins and needles, irritability, vomiting, insomnia, anxiety, sweating and fatigue were more common after stopping duloxetine than after stopping placebo. A 2024 meta-analysis of 79 studies found that about 31% of people had at least one discontinuation symptom after stopping an antidepressant, against 17% after placebo; severe symptoms affected about 3%.

The capsules cannot be opened or split, so tapering needs lower-strength capsules and a plan. Do not stop on your own.

Overdose and interactions

Duloxetine is much less dangerous in overdose than older tricyclic antidepressants. In a 2022 series from two toxicology units of 64 overdoses of duloxetine alone (median 840 mg), none needed intubation or had an arrhythmia. About half had a fast heart rate or mildly raised blood pressure, six had moderate Serotonin syndromeA reaction caused by too much serotonin in the body, usually from combining medicines that raise it. Symptoms range from shivering to high fever.More in the glossary and one had a seizure. The label does report deaths, including one at 1,000 mg alone. Any overdose needs hospital assessment: in the US call Poison Help on 1-800-222-1222, in the UK call 111, or 999 if someone is drowsy or fitting.

The interactions that matter most:

  • MAOI antidepressants, linezolid and IV methylene blue: ContraindicationA situation in which a medicine should not be used, because the risk clearly outweighs any benefit, such as a known allergy to it.More in the glossary.
  • Fluvoxamine raised duloxetine levels about 6-fold; ciprofloxacin and cimetidine also block its breakdown.
  • Duloxetine raises levels of drugs cleared by CYP450 enzymesA family of liver enzymes that break down many medicines. When another drug or supplement speeds them up or slows them down, drug levels change.More in the glossary, including tricyclics, flecainide and thioridazine (avoid).
  • Other serotonin drugs, including tramadol, triptans, other antidepressants and St John's wort.

Who should be careful

Talk to your doctor or pharmacist before starting duloxetine if you drink heavily or have liver disease, have severe kidney disease, take blood thinners, other antidepressants or pain medicines, have glaucoma, epilepsy, bipolar disorder or high blood pressure, are over 65 and prone to falls, or are pregnant. A lower score is not a reason to stop a medicine that is working; any change should be planned with your prescriber.

How we scored it

Track record (88) and Overdose marginHow far a normal dose is from a harmful one. A wide margin means an accidental extra dose is unlikely to cause serious harm.More in the glossary (75) are the strongest factors. Dependence (72) is lower than for long-acting SSRIs because withdrawal symptoms are common. Interactions (52) and regulatory warnings (48) reflect the CYP450 enzymesA family of liver enzymes that break down many medicines. When another drug or supplement speeds them up or slows them down, drug levels change.More in the glossary and CYP2D6 interactions, the liver warning and the class Boxed warningThe strongest safety warning the US FDA puts on a medicine's label, printed inside a black border at the top.More in the glossary.

Questions people ask

Is duloxetine bad for your liver?

Serious Drug-induced liver injuryLiver damage caused by a medicine, herbal product or supplement. It is usually rare and unpredictable, but it can be serious.More in the glossary is rare, but the Cymbalta label reports cases of liver failure, some fatal. In trials, 1.25% of people on duloxetine had a liver enzyme (ALT) rise above three times normal, against 0.45% on placebo. The label says it should not be prescribed to people with chronic liver disease or substantial alcohol use. Report yellow skin, dark urine or pain under the right ribs.

Can I drink alcohol while taking duloxetine?

The label says duloxetine does not add to the impairment that alcohol causes, but heavy drinking with duloxetine may be linked to severe Drug-induced liver injuryLiver damage caused by a medicine, herbal product or supplement. It is usually rare and unpredictable, but it can be serious.More in the glossary, and it advises avoiding heavy alcohol use. If you drink regularly, tell your prescriber before starting.

How long do duloxetine withdrawal symptoms last?

The label describes dizziness, headache, nausea, diarrhoea, pins and needles, irritability, insomnia and anxiety after stopping, usually short-lived but sometimes severe. Duloxetine leaves the body within a few days (half-life about 12 hours), so symptoms tend to start quickly. A slow, planned taper with your prescriber lowers the risk.

Why does duloxetine help with pain?

Duloxetine raises noradrenaline as well as serotonin, which damps pain signals in the spinal cord. That is why it is approved in the US for diabetic nerve pain, fibromyalgia and chronic musculoskeletal pain such as osteoarthritis and low back pain, as well as depression and anxiety. Pain doses stop at 60 mg a day.

Does duloxetine raise blood pressure?

Slightly, on average. Across the approved adult uses, systolic pressure rose by a mean 0.5 mmHg on duloxetine against a 0.6 mmHg fall on placebo. The label still advises checking blood pressure before and during treatment, and it can also cause dizziness on standing, especially in the first week.

Is duloxetine safe in pregnancy?

Data are limited. The label and the MHRA note a small extra risk of heavy bleeding after birth when SSRIs or SNRIs are used in the month before delivery. Untreated depression also carries risks, so do not stop on your own; talk to your doctor or midwife.

Sources

  1. 1.CYMBALTA (duloxetine delayed-release capsules) prescribing information (opens in a new tab) · DailyMed / Eli Lilly, 2025
  2. 2.Antidepressants: new safety measures for all patients to improve communication of the risk of suicidal thoughts and behaviours and persistent sexual dysfunction (opens in a new tab) · MHRA Drug Safety Update, 2026
  3. 3.Duloxetine overdose causes sympathomimetic and serotonin toxicity without major complications (opens in a new tab) · Clinical Toxicology, 2022
  4. 4.Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis (opens in a new tab) · Lancet Psychiatry (Henssler et al.), 2024
  5. 5.SSRI/SNRI antidepressant medicines: small increased risk of postpartum haemorrhage when used in the month before delivery (opens in a new tab) · MHRA Drug Safety Update, 2021
  6. 6.Duloxetine: marketed as Cymbalta and Yentreve for different disorders (opens in a new tab) · MHRA Drug Safety Update, 2007
  7. 7.Duloxetine drug usage statistics, United States, 2014 to 2024 (opens in a new tab) · ClinCalc DrugStats (MEPS data), 2026
Spot a mistake?